HIV/AIDS

The Three I's for HIV/TB

Key interventions to decrease the impact of TB on people living with HIV


Key facts

  • Tuberculosis (TB) is the leading cause of HIV-related deaths worldwide.
  • Of the 1.7 million people who died from TB in 2009, 400,000 (24%) were living with HIV.
  • Additionally in 2009 there were 9.4 million new cases of TB, of which 1.2 (13%) were among people living with HIV.
  • The risk of developing TB is estimated to be between 20-37 times greater in people living with HIV than among those without HV infection.

Key interventions

There is a strong scientific evidence base supporting that ART, by lowering a person’s viral load and restoring the immune system, significantly reduces the impact of HIV and TB. WHO recommends earlier ART at <350 CD4 and the immediate initiation of ART for all TB patients irrespective of CD4 count.

The Three I's for HIV/TB

In addition to initiating earlier antiretroviral therapy (ART), WHO recommends the implementation of the Three I's for HIV/TB to reduce the burden of TB among people living with HIV:

  • Intensified TB case finding
  • Isoniazid preventive therapy
  • Infection control for TB.

As resource-constrained countries rapidly expand HIV services prevention, treatment and care of TB in people living with HIV is an urgent priority for both HIV/AIDS and TB programmes. WHO recommends that the Three I's for HIV/TB in addition to ART be part of a TB prevention package and that emphasize that they should be core components of HIV services with AIDS programmes and service providers taking the primary responsibility for the Three I's for HIV/TB.

Related documents

Share

Last update:

22 May 2012 16:00 CEST